Robert Burk
Ponte Vedra Beach, FLNPI 1174630644
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 239 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. AbbVie accounts for 71.1% of it on its own, with 13 other manufacturers making up the rest.
Across 239 payments — averaging $38.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$6K
- Sientra, Inc.$1K
- Mentor Worldwide LLC$475
- Solta Medical, A Division Of Bausch Health US, LLC$275
- TELA Bio, Inc.$237
- Motiva USA, LLC$161
- plus $443 from 8 others
Across 5 payments — averaging $830.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- AbbVie$4K
What the payments were for
- Food & beverage$9,137100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 188 | $6,494 |
| Sientra, Inc. | 12 | $1,052 |
| Mentor Worldwide LLC | 11 | $475 |
| Solta Medical, A Division Of Bausch Health US, LLC | 3 | $275 |
| TELA Bio, Inc. | 3 | $237 |
| Motiva USA, LLC | 4 | $161 |
| Galderma Laboratories, L.p. | 7 | $101 |
| Innovation Technologies Inc | 1 | $101 |
| Davol Inc. | 3 | $90 |
| Smith+Nephew | 2 | $62 |
| Pacira Pharmaceuticals Incorporated | 2 | $36 |
| Surgical Specialties Corporation (US), Inc. (dba Corza Medical) | 1 | $20 |
| Apyx Medical Corporation | 1 | $18 |
| Pfizer | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ondansetron OdtOndansetron | 33 | $90 |
| Oxycodone Hcl | 21 | $52 |
| Tramadol Hcl | 12 | $27 |
Paid to pharmacies, not to this prescriber.
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.